Compare $NGNE vs $PROK | Chartloom

Compare

$NGNE vs $PROK

Neurogene Inc · Prokidney Corp

NGNE

Neurogene Inc

PROK

Prokidney Corp

Compare $NGNE vs $PROK

Comparing Neurogene Inc and Prokidney Corp

NGNENeurogene Inc

PROKProkidney Corp

NGNENeurogene Inc

Market cap

$521M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

31.0%

52W performance

2.2%

FCF yield

-16.8%

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NGNE

PROK

Detailed metrics comparison

NGNE

Neurogene Inc

PROK

Prokidney Corp

Market Cap

NGNE$521M

PROK$526M

Enterprise Value

NGNE$409M

PROK$451M

Price

NGNE$26.40

PROK$1.74

P/E Ratio

NGNEN/A

PROKN/A

P/S Ratio

NGNE0.00x

PROK642.52x

EV/Sales

NGNE0.00x

PROK551.08x

EV/EBITDA

NGNE0.00x

PROK0.00x

P/B Ratio

NGNE2.36x

PROK78.79x

P/FCF Ratio

NGNEN/A

PROKN/A

EV/FCF

NGNE-4.66x

PROK-2.82x

PEG Ratio

NGNEN/A

PROKN/A

Forward P/E (NTM)

NGNEN/A

PROKN/A

Forward P/S (NTM)

NGNEN/A

PROK788.85x

Revenue (TTM)

NGNE$0

PROK$818K

Revenue Growth (YoY)

NGNEN/A

PROK55.2%

Forward Rev Growth

NGNE127.3%

PROK-44.4%

Gross Margin (TTM)

NGNE0.0%

PROK0.0%

Operating Margin (TTM)

NGNE0.0%

PROK0.0%

EBITDA Margin (TTM)

NGNE0.0%

PROK-20827.6%

Net Margin (TTM)

NGNE0.0%

PROK-10288.4%

FCF Margin (TTM)

NGNEN/A

PROK-19527.4%

Net Income (TTM)

NGNE$-46M

PROK$-84M

FCF (TTM)

NGNE$-88M

PROK$-160M

EPS (TTM)

NGNE$0.00

PROK-$0.45

ROE (TTM)

NGNE-2527.0%

PROK-2810.2%

ROA (TTM)

NGNE-2325.0%

PROK-2739.0%

ROIC (TTM)

NGNE-2527.0%

PROK0.0%

Cash

NGNE$112M

PROK$75M

Debt

NGNE$8K

PROK$67K

Net Cash/Debt

NGNE$112M

PROK$75M

Current Ratio (TTM)

NGNE10.64x

PROK8.36x

Quick Ratio (TTM)

NGNE10.53x

PROK8.07x

Debt/Equity (TTM)

NGNE0.00x

PROK5.40x

Debt/Assets (TTM)

NGNE0.0%

PROK0.0%

Interest Coverage (TTM)

NGNEN/A

PROKN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

PROK0.00x

Beta

NGNE1.71

PROK1.95

52W Performance

NGNE2.2%

PROK-46.6%

YTD Performance

NGNE31.0%

PROK-22.0%

% from 52W High

NGNE-39.5%

PROK-50.0%

% from 52W Low

NGNE65.7%

PROK33.8%

Asset Turnover (TTM)

NGNE0.00x

PROK0.00x

FCF Yield (TTM)

NGNE-16.8%

PROK-30.4%

Earnings Yield (TTM)

NGNE-8.8%

PROK-16.0%

Dividend Yield (TTM)

NGNEN/A

PROKN/A

Rule of 40

NGNE0.0

PROK-19,472.2

EV/GP/RG

NGNEN/A

PROKN/A

Ticker research

View NGNE research View PROK research

Metric	NGNE Neurogene Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$521M	$526M
Enterprise Value	$409M	$451M
Price	$26.40	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.66x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	127.3%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-46M	$-84M
FCF (TTM)	$-88M	$-160M
EPS (TTM)	$0.00	-$0.45
ROE (TTM)	-2527.0%	-2810.2%
ROA (TTM)	-2325.0%	-2739.0%
ROIC (TTM)	-2527.0%	0.0%
Financial Health
Cash	$112M	$75M
Debt	$8K	$67K
Net Cash/Debt	$112M	$75M
Current Ratio (TTM)	10.64x	8.36x
Quick Ratio (TTM)	10.53x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	1.95
52W Performance	2.2%	-46.6%
YTD Performance	31.0%	-22.0%
% from 52W High	-39.5%	-50.0%
% from 52W Low	65.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.8%	-30.4%
Earnings Yield (TTM)	-8.8%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View PROK research

Valuation

P/S Ratio

NGNE

0.00x

PROK

642.52x

EV/FCF

NGNE

-4.66x

PROK

-2.82x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

Forward Revenue Growth

NGNE

127.3%

PROK

-44.4%

Profitability & performance

Gross Margin

NGNE

0.0%

PROK

0.0%

ROE

NGNE

-2527.0%

PROK

-2810.2%

FCF Yield %

NGNE

-16.8%

PROK

-30.4%

52-Week Performance

NGNE

2.2%

PROK

-46.6%

Detailed metrics comparison

NGNE

Neurogene Inc

PROK

Prokidney Corp

Market Cap

NGNE$521M

PROK$526M

Enterprise Value

NGNE$409M

PROK$451M

Price

NGNE$26.40

PROK$1.74

P/E Ratio

NGNEN/A

PROKN/A

P/S Ratio

NGNE0.00x

PROK642.52x

EV/Sales

NGNE0.00x

PROK551.08x

EV/EBITDA

NGNE0.00x

PROK0.00x

P/B Ratio

NGNE2.36x

PROK78.79x

P/FCF Ratio

NGNEN/A

PROKN/A

EV/FCF

NGNE-4.66x

PROK-2.82x

PEG Ratio

NGNEN/A

PROKN/A

Forward P/E (NTM)

NGNEN/A

PROKN/A

Forward P/S (NTM)

NGNEN/A

PROK788.85x

Revenue (TTM)

NGNE$0

PROK$818K

Revenue Growth (YoY)

NGNEN/A

PROK55.2%

Forward Rev Growth

NGNE127.3%

PROK-44.4%

Gross Margin (TTM)

NGNE0.0%

PROK0.0%

Operating Margin (TTM)

NGNE0.0%

PROK0.0%

EBITDA Margin (TTM)

NGNE0.0%

PROK-20827.6%

Net Margin (TTM)

NGNE0.0%

PROK-10288.4%

FCF Margin (TTM)

NGNEN/A

PROK-19527.4%

Net Income (TTM)

NGNE$-46M

PROK$-84M

FCF (TTM)

NGNE$-88M

PROK$-160M

EPS (TTM)

NGNE$0.00

PROK-$0.45

ROE (TTM)

NGNE-2527.0%

PROK-2810.2%

ROA (TTM)

NGNE-2325.0%

PROK-2739.0%

ROIC (TTM)

NGNE-2527.0%

PROK0.0%

Cash

NGNE$112M

PROK$75M

Debt

NGNE$8K

PROK$67K

Net Cash/Debt

NGNE$112M

PROK$75M

Current Ratio (TTM)

NGNE10.64x

PROK8.36x

Quick Ratio (TTM)

NGNE10.53x

PROK8.07x

Debt/Equity (TTM)

NGNE0.00x

PROK5.40x

Debt/Assets (TTM)

NGNE0.0%

PROK0.0%

Interest Coverage (TTM)

NGNEN/A

PROKN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

PROK0.00x

Beta

NGNE1.71

PROK1.95

52W Performance

NGNE2.2%

PROK-46.6%

YTD Performance

NGNE31.0%

PROK-22.0%

% from 52W High

NGNE-39.5%

PROK-50.0%

% from 52W Low

NGNE65.7%

PROK33.8%

Asset Turnover (TTM)

NGNE0.00x

PROK0.00x

FCF Yield (TTM)

NGNE-16.8%

PROK-30.4%

Earnings Yield (TTM)

NGNE-8.8%

PROK-16.0%

Dividend Yield (TTM)

NGNEN/A

PROKN/A

Rule of 40

NGNE0.0

PROK-19,472.2

EV/GP/RG

NGNEN/A

PROKN/A

Ticker research

View NGNE research View PROK research

Metric	NGNE Neurogene Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$521M	$526M
Enterprise Value	$409M	$451M
Price	$26.40	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	642.52x
EV/Sales	0.00x	551.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.36x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.66x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$0	$818K
Revenue Growth (YoY)	N/A	55.2%
Forward Rev Growth	127.3%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-20827.6%
Net Margin (TTM)	0.0%	-10288.4%
FCF Margin (TTM)	N/A	-19527.4%
Net Income (TTM)	$-46M	$-84M
FCF (TTM)	$-88M	$-160M
EPS (TTM)	$0.00	-$0.45
ROE (TTM)	-2527.0%	-2810.2%
ROA (TTM)	-2325.0%	-2739.0%
ROIC (TTM)	-2527.0%	0.0%
Financial Health
Cash	$112M	$75M
Debt	$8K	$67K
Net Cash/Debt	$112M	$75M
Current Ratio (TTM)	10.64x	8.36x
Quick Ratio (TTM)	10.53x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	1.95
52W Performance	2.2%	-46.6%
YTD Performance	31.0%	-22.0%
% from 52W High	-39.5%	-50.0%
% from 52W Low	65.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.8%	-30.4%
Earnings Yield (TTM)	-8.8%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View PROK research